Aurora Cannabis Urges Shareholders to Reject Revised Hostile Bid From Curaleaf
The board of directors at Aurora Cannabis Inc. (ACB) has unanimously recommended that shareholders reject a revised hostile acquisition proposal from Curaleaf. Company management stated that the updated offer significantly undervalues the business, emphasizing that Aurora operates with no debt and maintains a robust cash balance. Shares of the company traded down 2.29% at 5.97 CAD following the announcement.
The decision comes as Aurora continues an active review of strategic alternatives to maximize value for its shareholders. Curaleaf previously updated the terms of its takeover attempt on October 6, 2026, but Aurora has opened its data room to several other interested parties. The board highlighted its financial independence and balance sheet strength as key reasons to resist a change of control on current terms, advising investors not to take any action regarding the tender offer.
Investors should monitor whether Curaleaf raises its offer or if competing bids emerge from other companies currently evaluating Aurora's financial data. Curaleaf's hostile tender offer is set to remain open until December 4, 2026, establishing a deadline for potential alternative transactions, strategic partnerships, or revised proposals to take shape.
Key points
- Aurora Cannabis Inc. unanimously recommended that shareholders reject Curaleaf's revised takeover offer.
- The company stated the bid undervalues its business, noting a debt-free balance sheet and strong cash position.
- Curaleaf updated its hostile proposal on October 6, 2026, and the offer is scheduled to expire on December 4, 2026.
- Multiple third parties are currently reviewing financial information in Aurora's data room as part of a strategic review.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why did Aurora Cannabis reject Curaleaf's takeover offer?
Aurora Cannabis stated that Curaleaf's revised proposal undervalues the company, highlighting that Aurora is debt-free with a strong cash balance and is actively exploring alternative strategic options.
What is the deadline for Curaleaf's hostile bid for Aurora Cannabis?
Curaleaf's revised hostile offer for Aurora Cannabis is scheduled to remain open until December 4, 2026.
What should Aurora Cannabis shareholders do regarding the Curaleaf bid?
The board of directors of Aurora Cannabis has unanimously advised shareholders to take no action regarding Curaleaf's offer while the company evaluates strategic alternatives.